D. Ben-Shachar

P. Falkai, J. Thome, J. Kornhuber, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

J. Mann, L. Holper, D. Ben-Shachar, 2019, Neuropsychopharmacology.

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models

J. Mann, D. Ben-shachar, L. Holper, 2019, European Neuropsychopharmacology.

Entacapone augmentation of antipsychotic treatment in schizophrenic patients with negative symptoms; a double-blind placebo-controlled study.

H. Kaphzan, E. Klein, D. Ben-Shachar, 2014, The international journal of neuropsychopharmacology.

Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia

A. Kavushansky, H. Brenner-Lavie, D. Ben-Shachar, 2011, Biological Psychiatry.

Typical and Atypical Neuroleptics Induce Alteration in Blood‐Brain Barrier and Brain 59FeCl3 Uptake

K. Leenders, D. Ben-shachar, M. Youdim, 1994, Journal of neurochemistry.

NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia

R. Karry, O. Bergman, D. Ben-Shachar, 2018, Molecular Psychiatry.

Isolated Mitochondria Transfer Improves Neuronal Differentiation of Schizophrenia-Derived Induced Pluripotent Stem Cells and Rescues Deficits in a Rat Model of the Disorder

I. Weiner, B. Cohen, D. Ben-shachar, 2018, Schizophrenia bulletin.

Alternative Methods for Mitochondrial Transplantation: Efficiency of Unpackaged and Lipid-Packaged Preparations

D. Ben-shachar, DL McPhie, LW Sargent, 2017, bioRxiv.

The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia

D. Ben-Shachar, 2019, Journal of Neural Transmission.

Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?

Hila M. Ene, D. Ben-Shachar, 2017, Biological Psychiatry.

The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia

D. Ben-Shachar, 2009, Journal of Neural Transmission.

Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology.

Shunit Gal-Ben-Ari, Bella Smolin, Rachel Karry, 2012, The international journal of neuropsychopharmacology.

DNA methylation in vulnerability to post-traumatic stress in rats: evidence for the role of the post-synaptic density protein Dlgap2.

E. Klein, H. Cohen, D. Ben-Shachar, 2010, The international journal of neuropsychopharmacology.

Gene expression dynamics following mithramycin treatment: A possible model for post‐chemotherapy cognitive impairment

D. Ben-shachar, Eyal Asor, D. Ben-Shachar, 2018, Clinical and experimental pharmacology & physiology.

Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression

R. Karry, D. Ben-Shachar, 2008, PloS one.

Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2

R. Karry, D. Ben-Shachar, 2007, PloS one.

Effect of Iron Chelators on Dopamine D2 Receptors

D. Ben-shachar, J. Finberg, M. Youdim, 1985, Journal of neurochemistry.

The role of branched chain amino acid and tryptophan metabolism in rat’s behavioral diversity: Intertwined peripheral and brain effects

E. Ruppin, E. Klein, S. Stempler, 2015, European Neuropsychopharmacology.

Major depression as a disorder of serotonin resistance: inference from diabetes mellitus type II.

E. Klein, Y. Levy, B. Smolin, 2007, International Journal of Neuropsychopharmacology.

Alterations in cell adhesion molecule L1 and functionally related genes in major depression: A postmortem study

E. Klein, D. Laifenfeld, R. Karry, 2005, Biological Psychiatry.

The effects of bile acids on beta-adrenoceptors, fluidity, and the extent of lipid peroxidation in rat cardiac membranes.

D. Ben-shachar, U. Cogan, A. Bomzon, 2000, Biochemical pharmacology.

Brain Iron Uptake and Transport in Animal Model of Iron Deficiency, Tardive Dyskinesia and Neurodegenerative Diseases

K. Leenders, D. Ben-shachar, M. Youdim, 2001 .

Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder

G. Silberberg, R. Navon, D. Ben-Shachar, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

D. Ben-shachar, M. Youdim, J. Finberg, 1991, Journal of neurochemistry.

Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study

G. Agam, Y. Bersudsky, J. Levine, 2020, Scientific Reports.

Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells.

D. Ben-shachar, E. Klein, H. Brenner-Lavie, 2009, Biochemical pharmacology.

Mitochondrial Complex I as a Possible Novel Peripheral Biomarker for Schizophrenia

D. Ben-Shachar, 2009 .

Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia.

E. Klein, P. Ljubuncic, H. Brenner-Lavie, 2008, Biochimica et biophysica acta.

Mitochondria, synaptic plasticity, and schizophrenia.

D. Laifenfeld, D. Ben-Shachar, 2004, International review of neurobiology.

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

Dorit Ben-Shachar, D. Ben-Shachar, 2002, Journal of neurochemistry.

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.

P. Ljubuncic, R. Zuk, H. Gazawi, 2004, Biochemical pharmacology.

Mitochondrial respiratory states and rates

Sharma, Whiejong M. Han, Duchen, 2019 .

Platelets: A possible glance into brain biological processes in schizophrenia.

D. Ben-shachar, Eyal Asor, D. Ben-Shachar, 2012, World journal of psychiatry.

Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study

Nanette Freedman, Hava Lester, J. Aharon-Peretz, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

D. Ben-shachar, M. Tzukerman, E. Klein, 2002, Molecular Psychiatry.

Increased mitochondrial complex I activity in platelets of schizophrenic patients.

D. Ben-shachar, E. Klein, A. Reshef, 1999, The international journal of neuropsychopharmacology.

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

P. Riederer, P. Riederer, M. Gerlach, 1994, Journal of neurochemistry.

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

D. Ben-shachar, M. Youdim, D. Ben-Shachar, 1991, Journal of neurochemistry.

Dexamethasone in the presence of desipramine enhances MAPK/ERK1/2 signaling possibly via its interference with β-arrestin

D. Ben-shachar, E. Klein, R. Karry, 2013, Journal of Neural Transmission.

Paroxetine binding in aggressive schizophrenic patients

I. Modai, E. Klein, M. Ritsner, 2000, Psychiatry Research.

Update of Mitochondrial Network Analysis by Imaging: Proof of Technique in Schizophrenia.

D. Ben-shachar, Y. Yatchenko, D. Ben-Shachar, 2021, Methods in molecular biology.

Impaired heme metabolism in schizophrenia-derived cell lines and in a rat model of the disorder: Possible involvement of mitochondrial complex I

Hila M. Ene, D. Ben-Shachar, Lee S. Ifhar, 2019, European Neuropsychopharmacology.

Analysis of mitochondrial network by imaging: proof of technique in schizophrenia.

D. Ben-shachar, E. Suss-Toby, O. Robicsek, 2015, Methods in molecular biology.

Mitochondrial Complex I Subunits are Altered in Rats with Neonatal Ventral Hippocampal Damage but not in Rats Exposed to Oxygen Restriction at Neonatal Age

G. Agam, R. Karry, C. Nadri, 2009, Journal of Molecular Neuroscience.

Improved Generation of Induced Pluripotent Stem Cells From Hair Derived Keratinocytes – A Tool to Study Neurodevelopmental Disorders as ADHD

S. Walitza, E. Grünblatt, A. Doğan, 2018, Front. Cell. Neurosci..

Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders.

F. Müller, D. Ben-shachar, I. Petit, 2012, Stem cell research.

Mitochondria play an essential role in the trajectory of adolescent neurodevelopment and behavior in adulthood: evidence from a schizophrenia rat model

D. Farfara, R. Karry, Hila M. Ene, 2022, Molecular Psychiatry.

A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes.

S. Fuchs, M. Kotler, R. Strous, 2001, Proceedings of the National Academy of Sciences of the United States of America.

The effects of induced kynurenine pathway on immunocytochemical changes in rat tissues following excessive L-tryptophan consumption.

E. Livne, B. Gross, N. Ronen, 1996, Advances in experimental medicine and biology.

Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity

E. Klein, D. Laifenfeld, E. Grauer, 2005, Neurobiology of Disease.

Gene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat model

Eyal Asor, D. Ben-Shachar, 2016, World journal of psychiatry.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Iron-Deficiency Anaemia Modifies Brain Function Via Dopamine Receptor Subsensitivity

M. Youdim, S. Yehuda, D. Ben-Shachar, 1984 .

Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.

D. Ben-shachar, M. Youdim, B. Pinhassi, 1991, European journal of pharmacology.

Brain Iron and Dopamine D2 Receptors in the Rat

M. Youdim, D. Ben-Shachar, 1986 .

Nutritional iron and dopamine binding sites in the rat brain

D. Ben-shachar, M. Youdim, R. Ashkenazi, 1982, Pharmacology Biochemistry and Behavior.

Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain

E. Klein, H. Gazawi, D. Ben-Shachar, 1999, Brain Research.

The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease.

P. Riederer, D. Ben-shachar, M. Youdim, 1990, Journal of neural transmission. Supplementum.

Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior.

D. Ben-shachar, M. Youdim, S. Yehuda, 1989, The American journal of clinical nutrition.

Role of iron and iron chelation in dopaminergic‐induced neurodegeneration: Implication for Parkinson's disease

P. Riederer, M. Youdim, M. Youdim, 1992, Annals of neurology.

Iron regulation of dopaminergic transmission: relevance to movement disorders

D. Ben-shachar, M. Youdim, A. Tovi, 1993 .

Mitochondrial respiratory control and the protonmotive force: a conceptual perspective on coupling states in mitochondrial preparations

G. Brown, J. Muntané, A. Zorzano, 2017 .

Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: implication for the antidepressant effect of rTMS.

D. Ben-shachar, E. Klein, U. Shaul, 2003, The international journal of neuropsychopharmacology.

Iron in brain function and dysfunction with emphasis on Parkinson's disease.

P. Riederer, M. Youdim, D. Ben-Shachar, 1991, European neurology.

Transcranial magnetic stimulation induces alterations in brain monoamines

R. Belmaker, N. Grisaru, E. Klein, 2005, Journal of Neural Transmission.

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

P. Riederer, D. Ben-shachar, M. Youdim, 1989, Acta neurologica Scandinavica. Supplementum.

ATF2, A Member of the CREB/ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains

E. Klein, D. Laifenfeld, E. Grauer, 2004, Neuropsychopharmacology.

The enigma of neuromelanin in Parkinson's disease substantia nigra.

P. Riederer, D. Ben-shachar, M. Youdim, 1994, Journal of neural transmission. Supplementum.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression

E. Klein, D. Ben-Shachar, S. Yaniv, 2007, European Neuropsychopharmacology.

Iron and Parkinson’s Disease

P. Riederer, D. Ben-shachar, M. Youdim, 1994 .

The neurotoxic component in Parkinson’s disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra

D. Ben-shachar, M. Youdim, D. Ben-Shachar, 1990 .

The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.

P Riederer, P. Riederer, M. Youdim, 1993, Advances in neurology.

Increased mRNA levels of the mitochondrial complex I 75-kDa subunit

M. Gerlach, A. Warnke, C. Mehler-Wex, 2006, European Child & Adolescent Psychiatry.

Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates.

M. Youdim, S. Yehuda, R. Ashkenazi, 1984, Advances in neurology.

Neuromelanin and Nigrostriatal Dopamine Neuron Degeneration

K. Jellinger, P. Riederer, D. Ben-shachar, 1993, Journal of Neurochemistry.

Iron-Melanin Interaction in Substantia Nigra as the Neurotoxic Component of Parkinson’s Disease

P. Riederer, D. Ben-shachar, M. Youdim, 1990 .

Enhancing effects of fluoride-containing ceramic implants on bone formation in the dog femur.

M. Silbermann, E. Livne, D. Laufer, 1988, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

β-endorphin degradation and the individual reactivity to traumatic stress

M. Maroun, A. Kavushansky, E. Klein, 2013, European Neuropsychopharmacology.

Neuromelanin may Mediate Neurotoxicity via its Interaction with Redox Active Iron

P. Riederer, K. Double, M. Gerlach, 2000 .

S.07.05 The effects of transcranial magnetic stimulation on β-adrenergic receptors and brain monoamines

R. Belmaker, N. Grisaru, E. Klein, 1997, European Neuropsychopharmacology.

Iron and ferritin in substantia nigra in Parkinson's disease.

K. Jellinger, P. Riederer, M. Youdim, 1993, Advances in neurology.

Iron-Melanin Interaction and Parkinson's Disease

P. Riederer, M. Youdim, D. Ben-Shachar, 1993 .

The role of iron in the basal ganglion.

P. Riederer, D. Ben-shachar, M. Youdim, 1990, Advances in neurology.

NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia

R. Karry, O. Bergman, D. Ben-Shachar, 2018, Molecular Psychiatry.

Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder

G. Silberberg, R. Navon, D. Ben-Shachar, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Iron modulates neuroleptic-induced effects related to the dopaminergic system.

M. Youdim, E. Livne, R. Zuk, 1993, Israel journal of medical sciences.

β-endorphin degradation and the individual reactivity to traumatic stress

M. Maroun, A. Kavushansky, E. Klein, 2013, European Neuropsychopharmacology.

The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration

K. Jellinger, H. Reichmann, P. Riederer, 1990 .

The role of branched chain amino acid and tryptophan metabolism in rat’s behavioral diversity: Intertwined peripheral and brain effects

E. Ruppin, E. Klein, S. Stempler, 2015, European Neuropsychopharmacology.

Early postnatal interference with the expression of multiple Sp1 regulated genes leads to disparate behavioral response to sub-chronic and chronic stress in rats

A. Kavushansky, E. Klein, Eyal Asor, 2013, Psychoneuroendocrinology.